APA (7th ed.) Citation

Adachi, E., Saito, M., Koga, M., Tsutsumi, T., & Yotsuyanagi, H. (2022). Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS. Internal Medicine, 61(22), 3459-3462. https://doi.org/10.2169/internalmedicine.0485-22

Chicago Style (17th ed.) Citation

Adachi, Eisuke, Makoto Saito, Michiko Koga, Takeya Tsutsumi, and Hiroshi Yotsuyanagi. "Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS." Internal Medicine 61, no. 22 (2022): 3459-3462. https://doi.org/10.2169/internalmedicine.0485-22.

MLA (9th ed.) Citation

Adachi, Eisuke, et al. "Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS." Internal Medicine, vol. 61, no. 22, 2022, pp. 3459-3462, https://doi.org/10.2169/internalmedicine.0485-22.